3rd Quarter - Report

FERGUSON STRATEGIES, LLC for C.R. BARD INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

H.R. 436, the "Protect Medical Innovation Act." S.17, the "Medical Device Access and Innovation Protection Act." Reauthorization of the federal research and development tax credit. Policy issues relating to corporate tax reform.

LobbyistCovered position, as disclosed
ADAM HIGGINS —
CHRIS JONES —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 436 (112th), S. 17 (112th)

Manufacturing MAN

Policy issues related to proposed Securities and Exchange Commission regulations regarding implementation of Section 1502 of Public Law No. 111-203, the "Wall Street Reform and Consumer Protection Act."

LobbyistCovered position, as disclosed
ADAM HIGGINS —
CHRIS JONES —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to the Medical Device User Fee program. Policy and implementation issues related to Public Law No. 111-148, the "Patiet Protection and Affordable Care Act," including Accountable Care Organizations, the Independent Payment Advisory Board, and comparative effectiveness research.

LobbyistCovered position, as disclosed
ADAM HIGGINS —
CHRIS JONES —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Policy issues relating to the Centers for Medicare and Medicaid Services' Healthcare Common Procedure Coding System.

LobbyistCovered position, as disclosed
ADAM HIGGINS —
CHRIS JONES —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

H.J. Res.117, "Continuing Appropriations Resolution, 2013," specifically those sections relating to appropriations for the Food and Drug Admnistration's Center for Devices and Radiological Health. H.R. 5973 and S. 2375, the "FY 2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act," specifically those sections relating to appropriations for FDA's CDRH.

LobbyistCovered position, as disclosed
ADAM HIGGINS —
CHRIS JONES —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.J.Res. 117 (112th), S. 2375 (112th), H.R. 5973 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.